Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis

Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis

Show other versions (1)

The paper presents the data available in the literature on the efficacy and tolerability of basic tumor necrosis factor α inhibitors (TNF α) etanercept, adalimumab, infliximab in the treatment of psoriatic arthritis (PsA) and their effects on the major manifestations of this disease - cutaneous and...

Full description

Bibliographic Details
Main Authors: Vladimir Vasilyevich Badokin, I A Troshkina, Yu L Korsakova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2010-12-01
Series:Современная ревматология
Subjects:
tumor necrosis factor-α inhibitors
psoriatic arthritis
Online Access:http://mrj.ima-press.net/index.php/mrj/article/view/326

Internet

http://mrj.ima-press.net/index.php/mrj/article/view/326

Similar Items